| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |